In line with our results, a clinical study reported a higher Cathepsin E activity and expression in erythrocyte ghosts of healthy controls versus AD individuals [18], supporting the prospective role of Cathepsin E in the systemic response of AD. Here, CTSE is linked to Alzheimer disease.